Nuclivision Company
Nuclivision provides novel radiotracers and treatments for oncology that develop AI-driven solutions to help patients by improving the quality, safety, and accessibility of nuclear medicine.
Technology:
Biomarker Discovery & Validation
Founded Date:
2022-06-01 00:00:00
Industry:
BioPharma AI
Funding Status:
private
Headquarters:
Ghent,Oost-Vlaanderen,Belgium,Europe


